1-20 of 27
polymerase chain reaction
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal residual disease and stem cell transplantation outcomes

Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 617–625.
https://doi.org/10.1182/hematology.2019000006
Published: 2019
Journal Articles

MRD evaluation of AML in clinical practice: are we there yet?

Sylvie D. Freeman, Christopher S. Hourigan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 557–569.
https://doi.org/10.1182/hematology.2019000060
Published: 2019
Journal Articles

Molecular monitoring in CML: how deep? How often? How should it influence therapy?

Naranie Shanmuganathan, Timothy P. Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 168–176.
https://doi.org/10.1182/asheducation-2018.1.168
Published: 2018
Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.
https://doi.org/10.1182/asheducation-2016.1.356
Published: 2016
Journal Articles

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment

Eva Hoster, Christiane Pott
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 437–445.
https://doi.org/10.1182/asheducation-2016.1.437
Published: 2016
Journal Articles

Diagnosing von Willebrand disease: genetic analysis

Anne Goodeve
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 678–682.
https://doi.org/10.1182/asheducation-2016.1.678
Published: 2016
Journal Articles

Molecular monitoring in CML and the prospects for treatment-free remissions

Michael W. Deininger
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 257–263.
https://doi.org/10.1182/asheducation-2015.1.257
Published: 2015
Journal Articles

Helicobacter pylori and mucosa-associated lymphoid tissue: what's new

Sung-Hsin Kuo, Ann-Lii Cheng
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 109–117.
https://doi.org/10.1182/asheducation-2013.1.109
Published: 2013
Journal Articles

Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient

Martin Schrappe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 137–142.
https://doi.org/10.1182/asheducation.V2012.1.137.3798216
Published: 2012
Journal Articles

A look into the future: can minimal residual disease guide therapy and predict prognosis in chronic lymphocytic leukemia?

Paolo Ghia
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 97–104.
https://doi.org/10.1182/asheducation.V2012.1.97.3798195
Published: 2012
Journal Articles

Is going for cure in chronic myeloid leukemia possible and justifiable?

François-Xavier Mahon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 122–128.
https://doi.org/10.1182/asheducation.V2012.1.122.3798214
Published: 2012
Journal Articles

B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas

Adam Bagg
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 330–335.
https://doi.org/10.1182/asheducation-2011.1.330
Published: 2011
Journal Articles

Minimal Residual Disease in Acute Lymphoblastic Leukemia

Dario Campana
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 7–12.
https://doi.org/10.1182/asheducation-2010.1.7
Published: 2010
Journal Articles

Monitoring disease response to tyrosine kinase inhibitor therapy in CML

Timothy P. Hughes, Susan Branford
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 477–487.
https://doi.org/10.1182/asheducation-2009.1.477
Published: 2009
Journal Articles

Management of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph + ALL)

Oliver G. Ottmann, Heike Pfeifer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 371–381.
https://doi.org/10.1182/asheducation-2009.1.371
Published: 2009
Journal Articles

Initial treatment for patients with CML

John M. Goldman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 453–460.
https://doi.org/10.1182/asheducation-2009.1.453
Published: 2009
Journal Articles

ABL Kinase Inhibitor Therapy for CML: Baseline Assessments and Response Monitoring

Timothy Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 211–218.
https://doi.org/10.1182/asheducation-2006.1.211
Published: 2006
Journal Articles

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Randy D. Gascoyne
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 299–306.
https://doi.org/10.1182/asheducation-2005.1.299
Published: 2005
Journal Articles

Glossary

Alan M. Gewirtz, Josef T. Prchal, Kenneth Kaushansky
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 481–500.
https://doi.org/10.1182/asheducation-2004.1.481
Published: 2004
Journal Articles

Molecular Diagnostics

Rita M. Braziel, Margaret A. Shipp, Andrew L. Feldman, Virginia Espina, Mary Winters, Elaine S. Jaffe, Emanuel F. Petricoin, III, Lance A. Liotta
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 279–293.
https://doi.org/10.1182/asheducation-2003.1.279
Published: 2003